| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052119574 |
| P356 | DOI | 10.1007/S00436-015-4618-5 |
| P698 | PubMed publication ID | 26183607 |
| P50 | author | Neelagiri Soumya | Q66829569 |
| P2093 | author name string | Sushma Singh | |
| Neeradi Dinesh | |||
| P2860 | cites work | Mianserin, an antidepressant kills Leishmania donovani by depleting ergosterol levels | Q38982611 |
| Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication | Q39992673 | ||
| Mechanisms of statin-mediated inhibition of small G-protein function | Q40387534 | ||
| Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei. | Q41934019 | ||
| Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units | Q42079385 | ||
| Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase. | Q42091736 | ||
| Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development | Q42168234 | ||
| Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds | Q42225107 | ||
| Voriconazole suppresses the growth of Leishmania species in vitro | Q42275821 | ||
| Mevastatin inhibits proliferation of rat ovarian theca-interstitial cells by blocking the mitogen-activated protein kinase pathway | Q42501161 | ||
| Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum | Q42623845 | ||
| Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies | Q42628497 | ||
| The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth | Q42826831 | ||
| Kinetic properties and inhibition of Trypanosoma cruzi 3-hydroxy-3-methylglutaryl CoA reductase. | Q43860404 | ||
| Statin therapy: rationale for a new agent, rosuvastatin | Q44076446 | ||
| Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans | Q44678465 | ||
| Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells | Q44743426 | ||
| Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis | Q45098085 | ||
| Delta24(25)-sterol methenyltransferase: intracellular localization and azasterol sensitivity in Leishmania major promastigotes overexpressing the enzyme. | Q46591355 | ||
| Estimation of fungal growth using the ergosterol assay: a rapid tool in assessing the microbiological status of grains and feeds | Q46755806 | ||
| Role of simvastatin and methyl-β-cyclodextin on inhibition of poliovirus infection | Q57359503 | ||
| Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern | Q58805904 | ||
| The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway | Q77669992 | ||
| Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani | Q87673902 | ||
| Leishmaniasis worldwide and global estimates of its incidence | Q21134611 | ||
| Statins for the primary prevention of cardiovascular disease | Q24201513 | ||
| Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. | Q24535789 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| The discovery and development of HMG-CoA reductase inhibitors | Q28188527 | ||
| Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice | Q28209975 | ||
| Regulation of the mevalonate pathway | Q29547763 | ||
| Advances in leishmaniasis | Q29617229 | ||
| p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases | Q30311148 | ||
| A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line | Q31110522 | ||
| Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants | Q34020530 | ||
| Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa | Q34180978 | ||
| Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene | Q34301130 | ||
| Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity | Q34563795 | ||
| Statins: mechanism of action and effects. | Q34687736 | ||
| Who should receive HMG CoA reductase inhibitors? | Q34767394 | ||
| Immunomodulatory effects of HMG-CoA reductase inhibitors. | Q35190486 | ||
| Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation | Q35550354 | ||
| Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies | Q35810617 | ||
| A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells | Q36206948 | ||
| Clinical implications for statin pleiotropy | Q36308745 | ||
| Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs | Q37190868 | ||
| Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs | Q37579675 | ||
| In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum. | Q37643719 | ||
| Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin | Q37853574 | ||
| Leishmaniasis chemotherapy--challenges and opportunities | Q37935896 | ||
| Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis | Q38805947 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 3873-3883 | |
| P577 | publication date | 2015-07-18 | |
| P1433 | published in | Parasitology Research | Q15755242 |
| P1476 | title | Antileishmanial effect of mevastatin is due to interference with sterol metabolism | |
| P478 | volume | 114 |
| Q38875177 | Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis |
| Q38939544 | Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art |
| Q59349662 | Statins: a viable candidate for host-directed therapy against infectious diseases |
Search more.